GMF(SZ:002551) Sou Hu Cai Jing·2026-01-23 15:05Core Viewpoint - Shenzhen Shangrong Medical Co., Ltd. is expected to report significant losses for the fiscal year 2025, primarily due to various operational challenges and external market conditions [1] Financial Performance - The company's stock closed at 3.91 yuan on January 23, 2026, reflecting a 0.26% increase from the previous trading day, with a total market capitalization of 3.306 billion yuan [1] - The projected net profit attributable to shareholders for 2025 is expected to be between -170 million yuan and -120 million yuan, while the net profit after deducting non-recurring gains and losses is forecasted to be between -186.1926 million yuan and -136.1926 million yuan [1] Reasons for Losses - The anticipated losses are attributed to several factors, including: - A decrease in hospital engineering projects - Lower-than-expected receivables leading to increased bad debt provisions - A decline in revenue from medical consumables exports due to international market conditions, alongside rising costs - Increased foreign exchange losses due to currency fluctuations - Higher asset impairment provisions [1]